Showing results (731-740 of 1,628) with videos related to
Sort By:
Pageof 163
Mammalian Genome : Official Journal of the International Mammalian Genome Society|March 2, 1999
Genomic organization and chromosomal localization of mouse proteinase 3 (Myeloblastin)A Belaaouaj, C Moog-Lutz, J Just, et al.Infection and Immunity|June 19, 2013
Genetic analysis of the role of yfiR in the ability of Escherichia coli CFT073 to control cellular cyclic dimeric GMP levels and to persist in the urinary tractErica L Raterman, Daniel D Shapiro, Daniel J Stevens, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1991
Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinasesE J Campbell, J D Cury, S D Shapiro, et al.Journal of the American Heart Association|February 14, 2019
Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With EvolocumabMichael D Shapiro, Jessica Minnier, Hagai Tavori, et al.Nature Medicine|November 2, 2001
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapyB Wielockx, K Lannoy, S D Shapiro, et al.Radiation Research|July 1, 1993
Factors affecting the development of skin cancer after scalp irradiationB Modan, E Alfandary, D Shapiro, et al.The New England Journal of Medicine|October 24, 1996
Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study GroupM A Gerber, E D Shapiro, G S Burke, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 7, 2023
Plasminogen, human-tvmh for the treatment of children and adults with plasminogen deficiency type 1Amy D Shapiro, Charles Nakar, Joseph M Parker, et al.Biorxiv : the Preprint Server for Biology|August 7, 2023
Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2Fan Sun, Pengrong Yan, Yadong Xiao, et al.Neurodegenerative Disease Management|August 26, 2022
Relapses in people with multiple sclerosis treated with cladribine tablets followed for up to 5 years: a plain language summaryNicola De Stefano, Maria Pia Sormani, Gavin Giovannoni, et al.Pageof 163